BIIB

NASDAQ HEALTHCARE

Biogen Inc

$253.84

$12.86 (+5.34%)

Live quote

52w: $138.00 – $254.41

Loading chart…

P/E Ratio27.52

P/B Ratio1.91

EV/EBITDA—

Debt/Equity—

ROE6.93%

ROIC—

Revenue Growth2.22%

Gross Margin117.68%

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Own BIIB? Track it here.

Create a free account to add BIIB to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account